Flores, Analyn .
HRN: 04-88-81 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/22/2023
CEFUROXIME 1.5GM (VIAL)
10/22/2023
10/23/2023
IV
1.5gms
Q8hrs X 2 Doses
S/P Repeat CS For CPD
Checking Final Appropriateness
10/22/2023
CEFUROXIME 500MG (TAB)
10/23/2023
10/29/2023
PO
500mg
BID X 6 Days
S/P Repeat CS For CPD
Checking Final Appropriateness
10/23/2023
CEFUROXIME 500MG (TAB)
10/23/2023
10/29/2023
ORAL
500mg
BID
Sp Cs
Checking Final Appropriateness